Yahoo Movies Jaylen Brown with an alley oop vs the Miami Heat
Jaylen Brown (Boston Celtics) with an alley oop vs the Miami Heat, 11/30/2022
Jaylen Brown (Boston Celtics) with an alley oop vs the Miami Heat, 11/30/2022
Norway's $1.35 trillion wealth fund will step up its work on gender diversity on company boards this year and expand its focus beyond European and North American companies, a senior official at the fund told Reuters on Thursday. The fund voted against 171 board candidates at annual general meetings last year due to lack of diversity, it said in its annual report on responsible investments, out Thursday.
Credit card debt is also pretty common, despite the fact that it can be costly and financially harmful. As of the fourth quarter of 2022, U.S. credit card balances amounted to $930 billion, according to a recent report by TransUnion. When we compare that to Americans' collective $785 billion in credit card debt one year prior, it's clear that we're looking at a notable uptick.
Think Research Corporation (TSXV: THNK) ("Think" or the "Company"), a company focused on transforming healthcare through digital health software solutions, today announced that it entered into an agreement with a new customer on January 30, 2023, to provide a broad range of software solutions, data and subscription services to help improve access to quality healthcare. The value of this engagement is approximately $2.0 million.
Walmart (NYSE: WMT) and Amazon (NASDAQ: AMZN) have been going toe to toe over the years, battling each other in multiple forums. Amazon has expanded into grocery stores with the purchase of Whole Foods back in 2017. Walmart, meanwhile, has become more aggressive as an online retailer.
The Illinois Department of Health and Family Services says it will work with those who lose coverage navigate the ACA marketplace.
Figure 1 Location map of additional mineral tenure acquired at the Sting Project Figure 2 Map of Sting Project mineral tenure with regional NL Government residual magnetics VANCOUVER, British Columbia, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Vital Battery Metals Inc. (“Vital” or the “Company”) (CSE: VBAM) (OTCQB: VBAMF) (FSE: C0O), is pleased to announce that the Company has entered into an option agreement (the “Agreement”) to acquire a 100% interest in additional mineral tenure at the Sting Copper P
Adastra Holdings Ltd. (CSE:XTRX)(FRA:D2EP)("Adastra" or the "Company") a leading cannabis company and producer of two top Canadian concentrate brands, with a focus on processing, adult-use and medical sales, organoleptic and analytical testing, announces the termination of a legacy supply agreement for the Company's Phyto Extractions Brand ("Phyto").
Nextech AR Solutions Corp. ("Nextech" or the "Company") (OTCQX:NEXCF)(CSE:NTAR)(FSE:EP2), an Augmented Reality (AR), Artificial Intelligence (AI) and 3D model supplier for Amazon and other major e-commerce retailers and brands is pleased to announce the Company has landed another major enterprise customer.
PowerBand Solutions (TSXV:PBX)(OTCQB:PWWBF)(Frankfurt:1ZVA) ("PowerBand" "PBX"or the "Company"), a comprehensive e-commerce solution transforming the online experience to lease and finance vehicles, announces it has implemented additional cost restructuring measures to better align its operations to support changes in the automotive lease management industry.
PRINCETON, N.J., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release fourth quarter 2022 financial results on Wednesday, February 22, 2023, prior to the market open. In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. ET. A live webcast will be available on the Investors section of the Company’s website at investor.integralife.com. For those p
CANTON, Mass., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today announced that fourth quarter and fiscal year 2022 financial results will be reported after the market closes on Wednesday, March 1st. Management will host a conference call at 5:00 p.m. Eastern Time on Marc
The growth in the laboratory automation systems market is due to increased demand for microbiology testing and standardization of sample-collection devices for microbiology. North America region is expected to hold the largest laboratory automation systems market share.NEWARK, Del, Feb. 09, 2023 (GLOBE NEWSWIRE) -- During the forecast period, the lab automation market size is expected to register a CAGR of 10.1%. The market is anticipated to grow from a valuation of USD 2.1 billion in 2023 to US
Martin Madaus Repligen Appoints Martin Madaus to Board of Directors WALTHAM, Mass., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced the appointment to its Board of Directors of life sciences tools industry leader Martin D. Madaus. Dr. Madaus brings to the Repligen board over 25 years of industry experience, including five years as Chairman, President and Chief Executive Officer of Millipore Corporation, where he was integral to the company’s transformation in
Pathway Health Corp. (TSXV: PHC) ("Pathway" or the "Company") is pleased to announce that, further to its press release of February 3, 2023, it has elected to draw down $500,000 (the "Draw Down") under the $1.25 million secured convertible promissory grid note (the "Note") with HEAL Global Holdings Corp. (the "Lender"), an entity controlled by the Company's largest indirect beneficial shareholder Avonlea-Drewry Holdings Inc., and which is a party to the Company's previously announced letter of i
Surge Battery Metals Inc. (the "Company" or "Surge") (TSXV:NILI), (OTC PINK:NILIF), (FRA:DJ5C).
(TSXV:SEV) (OTCQB:SPVNF) Spectra7 Microsystems Inc. ("Spectra7" or the "Company"), a leading provider of high-performance analog semiconductor products for broadband connectivity markets, announced that it is targeting the high growth Artificial Intelligence (AI) server connectivity market with its new GC1122 product designed to support 800Gbps throughput.
PHOENIX, Feb. 09, 2023 (GLOBE NEWSWIRE) -- RAADR, Inc. (OTC PINK: RDAR), a technology and software development company that provides cutting edge solutions to detect and combat cyber-bullying and cyber-harassment throughout the internet on social media platforms announced today that it has successfully launched its RAADR™ iOS app. The RAADR™ iOS app can be downloaded for FREE at https://apps.apple.com/us/app/raadr/id1661624979. RAADR™ successfully launched its RAADR™ application for Android user
SAFETY HARBOR, Florida, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Cryptyde, Inc. (NASDAQ: TYDE), a company dedicated to fostering growth and innovation through strategic acquisitions and management, announces a significant achievement of its wholly-owned subsidiary, Forever 8. The e-commerce cash flow management solutions company has recorded its first day of revenue exceeding $1 million, showcasing its persistent growth and expanding presence in the e-commerce industry. "We are delighted to report Fore
TORONTO, Feb. 09, 2023 (GLOBE NEWSWIRE) -- AmmPower Corp. (CSE: AMMP) (OTCQB: AMMPF) (FSE: 601A) (the “Company” of “AmmPower”) is pleased to announce that it has entered into a Memorandum of Understanding with the Port of Corpus Christi Authority (“PCCA”) to explore the development of a green hydrogen used as feedstock for green fuel and green derivatives production, storage and distribution facility. As previously announced on January 10, 2023, AmmPower has been named as one of the Private Sect
– Phase 1 trial showed 30% CR rate among 20 NPM1-mutant AML patients treated at recommended Phase 2 dose – – Phase 2 registration-directed trial expected to enroll 85 patients in the U.S. and Europe – SAN DIEGO, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that the first patients have been dosed in its KOMET-001 Phase 2 registr